Dear colleague,

The 10ᵗʰ International Symposium on Hodgkin Lymphoma (ISHL10) will be held in Cologne, Germany, between October 22 and 25, 2016.

ISHL10 will cover all most recent results in basic research, diagnostics and treatment of Hodgkin Lymphoma. There will be a special emphasis on new treatment approaches with a focus on immunotherapy. Workshops and Satellite Symposia will complement the program.

In addition, there will be interactive case discussions and a comprehensive Educational Session on Hematology.

We are delighted to announce that the key note lecture entitled “Immune checkpoint blockade in Hodgkin Lymphoma” will be given by Margaret A. Shipp, MD, Dana-Farber/Harvard Cancer Center during the Opening Ceremony.

Dr. Shipp’s clinical and laboratory research focuses on the clinical and molecular heterogeneity of Hodgkin and large B-cell lymphomas (LBCLs) and includes the identification of unique lymphoma subtypes amenable to targeted therapy. She is the recipient of numerous awards.

We highly appreciate the support of our Scientific Committee. For more information, please go to our homepage.

See you at ISHL10 in 2016!

Andreas Engert, MD, Congress and GHSG Chairman

Boris Böll, MD, Congress Secretary

Bastian von Tresckow, MD, Congress Secretary